| 1 |
Marques LLM, Beneti SC, Pinzon C, Cardoso FAR. Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols. Braz J Biol 2024;84:e258325. [DOI: 10.1590/1519-6984.258325] [Reference Citation Analysis]
|
| 2 |
Kiuru C, Ominde K, Muturi M, Babu L, Kung'u CW, Chaccour C, Maia MF. Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s.. [DOI: 10.21203/rs.3.rs-2643522/v1] [Reference Citation Analysis]
|
| 3 |
Kern C, Mueller P, Chaccour C, Liechti ME, Hammann F, Duthaler U. Clinical pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes.. [DOI: 10.21203/rs.3.rs-2549867/v1] [Reference Citation Analysis]
|
| 4 |
Eba K, Habtewold T, Asefa L, Degefa T, Yewhalaw D, Duchateau L. Effect of Ivermectin(®) on survivorship and fertility of Anopheles arabiensis in Ethiopia: an in vitro study. Malar J 2023;22:12. [PMID: 36624480 DOI: 10.1186/s12936-023-04440-6] [Reference Citation Analysis]
|
| 5 |
Kumar G, Pasi S, Yadav CP, Kaur J, Sharma A. Potential of ivermectin as an active ingredient of the attractive toxic sugar baits against the Indian malaria vectors Anopheles culicifacies and Anopheles stephensi. Pest Manag Sci 2023;79:474-80. [PMID: 36176013 DOI: 10.1002/ps.7217] [Reference Citation Analysis]
|
| 6 |
Karisa J, Ominde K, Muriu S, Munyao V, Mwikali K, Babu L, Ondieki Z, Bartilol B, Tuwei M, Wanjiku C, Maia M, Midega J, Rono M, Peshu N, Mbogo C, Mwangangi JM. Malaria vector bionomics in Taita-Taveta County, coastal Kenya. Parasites Vectors 2022;15:430. [DOI: 10.1186/s13071-022-05527-w] [Reference Citation Analysis]
|
| 7 |
Saha T, Sinha S, Harfoot R, Quiñones-Mateu ME, Das SC. Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder. Pharmaceutics 2022;14. [PMID: 35890327 DOI: 10.3390/pharmaceutics14071432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Dueñas-gonzález A, Juárez-rodríguez M. Ivermectin: Potential Repurposing of a Versatile Antiparasitic as a Novel Anticancer. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.99813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Fimbo AM, Minzi OM, Mmbando BP, Gurumurthy P, Kamuhabwa AAR, Aklillu E. Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study. Pharmaceuticals (Basel) 2022;15. [PMID: 35631420 DOI: 10.3390/ph15050594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Sabry N, Fouad Y, AbdAllah M, Cordie A, Esmat G. Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status. Am J Ther 2022. [PMID: 35383577 DOI: 10.1097/MJT.0000000000001490] [Reference Citation Analysis]
|
| 11 |
Albariqi AH, Wang Y, Yoon Kyung Chang R, Quan DH, Wang X, Kalfas S, Drago J, Britton WJ, Chan HK. Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment. Int J Pharm 2022;:121688. [PMID: 35314278 DOI: 10.1016/j.ijpharm.2022.121688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Scheim DE. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int J Mol Sci 2022;23:2558. [PMID: 35269703 DOI: 10.3390/ijms23052558] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 13 |
Yenew C, Mulatu S, Alamneh A. The Trend of Malaria Cases, Positivity Rate, and Determinant Factors in the Amhara Regional State, Ethiopia: A Mixed Method. Case Rep Infect Dis 2021;2021:2131720. [PMID: 34966565 DOI: 10.1155/2021/2131720] [Reference Citation Analysis]
|
| 14 |
Chandiwana NC, Serenata CM, Owen A, Rannard S, Pérez Casas C, Scott C, Hill A, Clayden P, Flexner C. Impact of long-acting therapies on the global HIV epidemic. AIDS 2021;35:S137-43. [PMID: 34848580 DOI: 10.1097/QAD.0000000000003102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Shagufta, Ahmad I. An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS-CoV-2 Activity. ChemistrySelect 2021;6:11502-27. [PMID: 34909460 DOI: 10.1002/slct.202103301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 16 |
Mathachan SR, Sardana K, Khurana A. Current Use of Ivermectin in Dermatology, Tropical Medicine, and COVID-19: An Update on Pharmacology, Uses, Proven and Varied Proposed Mechanistic Action. Indian Dermatol Online J 2021;12:500-14. [PMID: 34430453 DOI: 10.4103/idoj.idoj_298_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Kositz C, Bradley J, Hutchins H, Last A, D'Alessandro U, Marks M. Broadening the range of use cases for ivermectin - a review of the evidence. Trans R Soc Trop Med Hyg 2021:trab114. [PMID: 34323283 DOI: 10.1093/trstmh/trab114] [Reference Citation Analysis]
|
| 18 |
Ayankunle AA, Wakeel OK, Kolawole OT, Oyekale AO, Ojurongbe O, Adeyeba OA. Drug Repositioning: Antimalarial Activities of GABA Analogs in Mice Infected with Plasmodium berghei. Cent Nerv Syst Agents Med Chem 2020;20:110-21. [PMID: 32496991 DOI: 10.2174/1871524920666200604151907] [Reference Citation Analysis]
|
| 19 |
Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, Álvarez L, Fleitas PE, Ceballos L, Golemba M, Fernández F, Fernández de Oliveira D, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C. Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial. EClinicalMedicine 2021;37:100959. [PMID: 34189446 DOI: 10.1016/j.eclinm.2021.100959] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 20 |
de Souza DK, Thomas R, Bradley J, Leyrat C, Boakye DA, Okebe J. Ivermectin treatment in humans for reducing malaria transmission. Cochrane Database Syst Rev 2021;6:CD013117. [PMID: 34184757 DOI: 10.1002/14651858.CD013117.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Shukla DAK, Misra DS. Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? Int J Infect Dis 2021;109:91. [PMID: 34175482 DOI: 10.1016/j.ijid.2021.06.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Duthaler U, Leisegang R, Karlsson MO, Krähenbühl S, Hammann F. The effect of food on the pharmacokinetics of oral ivermectin. J Antimicrob Chemother 2020;75:438-40. [PMID: 31691813 DOI: 10.1093/jac/dkz466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Matamoros G, Sánchez A, Gabrie JA, Juárez M, Ceballos L, Escalada A, Rodríguez C, Martí-Soler H, Rueda MM, Canales M, Lanusse C, Cajal P, Álvarez L, Cimino RO, Krolewiecki A. Efficacy and safety of albendazole and high-dose ivermectin co-administration in school-aged children infected with Trichuris trichiura in Honduras: A Randomized Controlled Trial. Clin Infect Dis 2021:ciab365. [PMID: 33906234 DOI: 10.1093/cid/ciab365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Duthaler U, Weber M, Hofer L, Chaccour C, Maia M, Müller P, Krähenbühl S, Hammann F. The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes. PLoS Pathog 2021;17:e1009382. [PMID: 33730100 DOI: 10.1371/journal.ppat.1009382] [Reference Citation Analysis]
|
| 25 |
Elalfy H, Besheer T, El-Mesery A, El-Gilany AH, Soliman MA, Alhawarey A, Alegezy M, Elhadidy T, Hewidy AA, Zaghloul H, Neamatallah MAM, Raafat D, El-Emshaty WM, Abo El Kheir NY, El-Bendary M. Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19. J Med Virol 2021;93:3176-83. [PMID: 33590901 DOI: 10.1002/jmv.26880] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 26 |
Welch E, Romani L, Whitfeld MJ. Recent advances in understanding and treating scabies. Fac Rev 2021;10:28. [PMID: 33817697 DOI: 10.12703/r/10-28] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Kern C, Schöning V, Chaccour C, Hammann F. Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. Front Pharmacol 2021;12:625678. [PMID: 33776767 DOI: 10.3389/fphar.2021.625678] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 28 |
Coulibaly S, Péguédwindé Sawadogo S, Sawdetuo Hien A, Sindimbasba Nikièma A, Sangaré I, Rabila B, Koala L, Bougouma C, Windtaré Bougma R, Anicet Ouedraogo G, Kounbobr Dabiré R. Malaria and Lymphatic Filariasis Co-Transmission in Endemic Health Districts in Burkina Faso. AE 2021;09:155-175. [DOI: 10.4236/ae.2021.94014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Chaccour C. Veterinary endectocides for malaria control and elimination: prospects and challenges. Philos Trans R Soc Lond B Biol Sci 2021;376:20190810. [PMID: 33357062 DOI: 10.1098/rstb.2019.0810] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 30 |
Dos Passos JBS, Coelho LV, de Arruda JAA, Silva LVO, do Valle IB, Santos MS, de Figueiredo EL, Abreu LG, Mesquita RA. Oral myiasis: Analysis of cases reported in the English literature from 1990 to 2020. Spec Care Dentist 2021;41:20-31. [PMID: 33125723 DOI: 10.1111/scd.12533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Kouznetsov VV. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus. Eur J Med Chem 2020;203:112647. [PMID: 32693298 DOI: 10.1016/j.ejmech.2020.112647] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 32 |
Kouznetsov VV. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus. Eur J Med Chem 2020;203:112647. [PMID: 32693298 DOI: 10.1016/j.ejmech.2020.112647] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 33 |
Yurdakök Dikmen B, Pat Y, Dilekoz E, Summak GY, Kul O, Filazi A. COVID-19 FARMAKOTERAPİSİ. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni 2020;11:80-114. [DOI: 10.38137/vetfarmatoksbulten.769889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 34 |
Snawerdt J, Finoli L, Bremmer DN, Cheema T, Bhanot N. Therapeutic Options for the Treatment of Coronavirus Disease (COVID-19). Crit Care Nurs Q 2020;43:349-68. [PMID: 32833772 DOI: 10.1097/CNQ.0000000000000321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Wang D, Huang J, Yeung AWK, Tzvetkov NT, Horbańczuk JO, Willschke H, Gai Z, Atanasov AG. The Significance of Natural Product Derivatives and Traditional Medicine for COVID-19. Processes 2020;8:937. [DOI: 10.3390/pr8080937] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 36 |
Chaccour C, Hammann F, Ramón-García S, Rabinovich NR. Ivermectin and COVID-19: Keeping Rigor in Times of Urgency. Am J Trop Med Hyg 2020;102:1156-7. [PMID: 32314704 DOI: 10.4269/ajtmh.20-0271] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 33.3] [Reference Citation Analysis]
|
| 37 |
Wadi I, Singh P, Nath M, Anvikar AR, Sinha A. Malaria transmission-blocking drugs: implications and future perspectives. Future Med Chem 2020;12:1071-101. [PMID: 32378423 DOI: 10.4155/fmc-2020-0026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 38 |
Billingsley P, Binka F, Chaccour C, Foy B, Gold S, Gonzalez-Silva M, Jacobson J, Jagoe G, Jones C, Kachur P, Kobylinski K, Last A, Lavery JV, Mabey D, Mboera D, Mbogo C, Mendez-Lopez A, Rabinovich NR, Rees S, Richards F, Rist C, Rockwood J, Ruiz-Castillo P, Sattabongkot J, Saute F, Slater H, Steer A, Xia K, Zullinger R; The Ivermectin Roadmappers. A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool. Am J Trop Med Hyg 2020;102:3-24. [PMID: 31971144 DOI: 10.4269/ajtmh.19-0620] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 39 |
Gerunov TV. IMMUNOTROPIC EFFECTS OF IVERMECTIN IN PRODUCTIVE AND LABORATORY ANIMALS. Toksikologičeskij vestnik 2020. [DOI: 10.36946/0869-7922-2020-1-49-53] [Reference Citation Analysis]
|
| 40 |
Meredith HR, Furuya-Kanamori L, Yakob L. Optimising systemic insecticide use to improve malaria control. BMJ Glob Health 2019;4:e001776. [PMID: 31798988 DOI: 10.1136/bmjgh-2019-001776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 41 |
Duthaler U, Suenderhauf C, Gaugler S, Vetter B, Krähenbühl S, Hammann F. Development and validation of an LC-MS/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system. Journal of Pharmaceutical and Biomedical Analysis 2019;172:18-25. [DOI: 10.1016/j.jpba.2019.04.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 42 |
Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: Scabies. J Am Acad Dermatol 2020;82:533-48. [PMID: 31310840 DOI: 10.1016/j.jaad.2019.05.109] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 43 |
Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, Enbiale W, Engels D, Hay RJ, Hendrickx D, Hotez PJ, Kaldor JM, Kama M, Mackenzie CD, McCarthy JS, Martin DL, Mengistu B, Maurer T, Negussu N, Romani L, Sokana O, Whitfeld MJ, Fuller LC, Steer AC. The public health control of scabies: priorities for research and action. Lancet 2019;394:81-92. [PMID: 31178154 DOI: 10.1016/S0140-6736(19)31136-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 44 |
Nicolas JM, de Lange ECM. Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity. AAPS J 2019;21:67. [PMID: 31140038 DOI: 10.1208/s12248-019-0340-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 45 |
Brussee JM, Schulz JD, Coulibaly JT, Keiser J, Pfister M. Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults. Clin Pharmacol Ther 2019;106:661-7. [PMID: 30993667 DOI: 10.1002/cpt.1456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 46 |
Ashour DS. Ivermectin: From theory to clinical application. Int J Antimicrob Agents 2019;54:134-42. [PMID: 31071469 DOI: 10.1016/j.ijantimicag.2019.05.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 47 |
Meredith HR, Furuya-kanamori L, Yakob L. Optimizing systemic insecticide use to improve malaria control.. [DOI: 10.1101/621391] [Reference Citation Analysis]
|
| 48 |
Chaccour C, Rabinovich NR. Advancing the repurposing of ivermectin for malaria. Lancet 2019;393:1480-1. [PMID: 30878223 DOI: 10.1016/S0140-6736(18)32613-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 49 |
Imbahale SS, Montaña Lopez J, Brew J, Paaijmans K, Rist C, Chaccour C. Mapping the potential use of endectocide-treated cattle to reduce malaria transmission. Sci Rep 2019;9:5826. [PMID: 30967606 DOI: 10.1038/s41598-019-42356-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 50 |
Nguyen C, Gray M, Burton TA, Foy SL, Foster JR, Gendernalik AL, Rückert C, Alout H, Young MC, Boze B, Ebel GD, Clapsaddle B, Foy BD. Evaluation of a novel West Nile virus transmission control strategy that targets Culex tarsalis with endectocide-containing blood meals. PLoS Negl Trop Dis 2019;13:e0007210. [PMID: 30845250 DOI: 10.1371/journal.pntd.0007210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 51 |
Duthaler U, Suenderhauf C, Karlsson MO, Hussner J, Meyer Zu Schwabedissen H, Krähenbühl S, Hammann F. Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers. Br J Clin Pharmacol 2019;85:626-33. [PMID: 30566757 DOI: 10.1111/bcp.13840] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 52 |
Jones AK. How Complex Can Resistance to Dieldrin, the Insect γ-Aminobutyric Acid Receptor, Get? Int J Insect Sci 2018;10:1179543318804782. [PMID: 30559597 DOI: 10.1177/1179543318804782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 53 |
Chhonker YS, Ma L, Edi C, Murry DJ. A sensitive and selective LC-MS/MS method for quantitation of ivermectin in human, mouse and monkey plasma: clinical validation. Bioanalysis 2018;10:1841-52. [PMID: 30325218 DOI: 10.4155/bio-2018-0110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 54 |
Ng'habi K, Viana M, Matthiopoulos J, Lyimo I, Killeen G, Ferguson HM. Mesocosm experiments reveal the impact of mosquito control measures on malaria vector life history and population dynamics. Sci Rep 2018;8:13949. [PMID: 30224714 DOI: 10.1038/s41598-018-31805-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Amanzougaghene N, Fenollar F, Nappez C, Ben-Amara A, Decloquement P, Azza S, Bechah Y, Chabrière E, Raoult D, Mediannikov O. Complexin in ivermectin resistance in body lice. PLoS Genet 2018;14:e1007569. [PMID: 30080859 DOI: 10.1371/journal.pgen.1007569] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 56 |
Badhan R, Zakaria Z, Olafuyi O. The Repurposing of Ivermectin for Malaria: A Prospective Pharmacokinetics-Based Virtual Clinical Trials Assessment of Dosing Regimen Options. Journal of Pharmaceutical Sciences 2018;107:2236-50. [DOI: 10.1016/j.xphs.2018.03.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Amanzougaghene N, Fenollar F, Diatta G, Sokhna C, Raoult D, Mediannikov O. Mutations in GluCl associated with field ivermectin-resistant head lice from Senegal. Int J Antimicrob Agents 2018;52:593-8. [PMID: 30055248 DOI: 10.1016/j.ijantimicag.2018.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 58 |
Beier JC, Wilke AB, Benelli G. Newer Approaches for Malaria Vector Control and Challenges of Outdoor Transmission. Towards Malaria Elimination - A Leap Forward 2018. [DOI: 10.5772/intechopen.75513] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 59 |
Chaccour CJ, Ngha'bi K, Abizanda G, Irigoyen Barrio A, Aldaz A, Okumu F, Slater H, Del Pozo JL, Killeen G. Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation. Parasit Vectors 2018;11:287. [PMID: 29728135 DOI: 10.1186/s13071-018-2872-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 60 |
Maroccia Z, Loizzo S, Travaglione S, Frank C, Fabbri A, Fiorentini C. New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1. Biomed Pharmacother 2018;101:929-37. [PMID: 29635902 DOI: 10.1016/j.biopha.2018.02.140] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 61 |
Taylor-wells J, Senan A, Bermudez I, Jones AK. Species specific RNA A-to-I editing of mosquito RDL modulates GABA potency and influences agonistic, potentiating and antagonistic actions of ivermectin. Insect Biochemistry and Molecular Biology 2018;93:1-11. [DOI: 10.1016/j.ibmb.2017.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 62 |
Muñoz J, Ballester MR, Antonijoan RM, Gich I, Rodríguez M, Colli E, Gold S, Krolewiecki AJ. Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers. PLoS Negl Trop Dis 2018;12:e0006020. [PMID: 29346388 DOI: 10.1371/journal.pntd.0006020] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 63 |
Benelli G, Beier JC. Current vector control challenges in the fight against malaria. Acta Trop 2017;174:91-6. [PMID: 28684267 DOI: 10.1016/j.actatropica.2017.06.028] [Cited by in Crossref: 173] [Cited by in F6Publishing: 181] [Article Influence: 28.8] [Reference Citation Analysis]
|
| 64 |
Chaccour CJ, Hammann F, Alustiza M, Castejon S, Tarimo BB, Abizanda G, Irigoyen Barrio Á, Martí Soler H, Moncada R, Bilbao JI, Aldaz A, Maia M, Del Pozo JL. Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae. Sci Rep 2017;7:8535. [PMID: 28819225 DOI: 10.1038/s41598-017-08906-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 65 |
Ōmura S, Crump A. Ivermectin and malaria control. Malar J 2017;16:172. [PMID: 28438169 DOI: 10.1186/s12936-017-1825-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 66 |
Chaccour C, Rabinovich NR. Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways. Malar J 2017;16:162. [PMID: 28434407 DOI: 10.1186/s12936-017-1803-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 67 |
Chaccour C, Rabinovich NR. Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway. Malar J 2017;16:166. [PMID: 28434405 DOI: 10.1186/s12936-017-1802-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 68 |
Scheim D. From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature. SSRN Journal. [DOI: 10.2139/ssrn.3706347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 69 |
Scheim D. Ivermectin for COVID-19 Treatment: Clinical Response at Quasi-Threshold Doses Via Hypothesized Alleviation of CD147-Mediated Vascular Occlusion. SSRN Journal. [DOI: 10.2139/ssrn.3636557] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
|
